Breast pathology handling by breast radiologists in a high incidence hospital for COVID-19
DOI:
https://doi.org/10.19230/jonnpr.3974Keywords:
Management, Guidelines, Breast Cancer, COVID-19, Pandemic, SEDIM, GEICAM, PBBC, SEOMAbstract
In this article we would like to show the reader how we have managed breast pathology along all pandemic COVID-19 period in our Radiology Department, as far as our Hospital (“Complejo Hospitalario Universtiario de Albacete”) has been highly affected by COVID-19. To get to a result, we have revised main breast management guides porpused by different societies, and we have afterwards compared their recommendations with our way of handling the situation, taking into account that some of them were available and others were modified in order to benefit our patients. This was necessary in order to satisfy the attention of our patients with non delaying breast pathology and to manage correctly COVID-19 pandemic as well in a high incidence place. Our principal aims have been avoiding breast pathology diagnosis delay (breast cancer above all), as well as avoiding workers and patients COVID-19 infection.
Downloads
References
Guerrero A., Montero A., Jara C. et al. Documento GEICAM sobre el manejo del paciente con cáncer de mama en la situación de pandemia de COVID-19 en España. España: SEDIM; 2020 [Consultado 5 Ago 2020]. Disponible en: http://www.sedim.es/nueva/wp-content/uploads/2019/10/GEICAM-COVID-19-y-Cancer-de-Mama-VF-enviado.pdf
Dietz J., Moran M., Isakoff S. et al. Recommendations for Priorization, Treatment and Triage of Breast Cancer Patients During the COVID-19 Pandemic. EEUU: PBCC; 2020 [Consultado 5 Ago 2020]. Disponible en: http://www.sedim.es/nueva/wp-content/uploads/2019/10/The_COVID-19_Pandemic_Breast_Cancer_Consortium_Recommendations.pdf
Vázquez Albaladejo C., Pardo R., Piñero A. Influencia de la pandemia por SARS-COV-2 en el manejo del a patología mamaria. SESPM. 2020 [Consultado 28 Ago 2020]. DIsponible en: https://www.sespm.es/resumen-del-webinar-influencia-de-la-pandemia-por-sars-cov-2-en-el-manejo-de-la-patologia-mamaria-organizado-por-sespm/
Sociedad Española de Oncología Médica. Recomendaciones SEOM sobre la infección por coronavirus SARS-CoV-2. España: SEOM; 2020 [Consultado 28 Ago 2020]. Disponible en: https://seom.org/images/RECOMENDACIONES_SEOM_COV19_marzo2020.pdf
Canadian Association of Radiologists. The Canadian Society of Breast Imaging (CSBI) and the Canadian Association of Radiology (CAR) Guidelines for Breast Imaging during the COVID-19 Pandemic. Canada: CSBI; 2020 [Consultado 5 Ago 2020]. Disponible en: https://csbi.ca/wp-content/uploads/2020/04/CAR-CSBI_Breast_Imaging_Guidelines_During_COVID-19_2020_04_02_EG.pdf
Organización Mundial de la Salud. Rational use of personal protective equipment (PPE) for coronavirus disease (COVID-19). Suiza: OMS; 2020 [Consultado 28 Ago 2020]. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/331695/WHO-2019-nCov-IPC_PPE_use-2020.3-eng.pdf?sequence=9&isAllowed=y
COVID 19 Pandemic Breast Cancer Consortium (NAPBC, CoC, ASBrS, NCCN). COVID-19 Guidelines for Triage of Breast Cancer Patients. EEUU: PBCC; 2020 [Consultado 28 Ago 2020]. Disponible en: https://www.facs.org/covid-19/clinical-guidance/elective-case/breast-cancer
Seely J., Scaranelo A., Yong-Hing C. et al. Safe Guidelines for Breast Imaging During the Pandemic. SAGE. 2020; 71 (4): 459-469.
Iranzo González V. Abordaje multidisciplinar del tratamiento neoadyuvante del cáncer de mama. SEOM. 2020. [Consultado 29 Ago 2020]. Disponible en: http://www.gruposolti.org/documents/20182/55949/REUNI%C3%93N+SOLTI_26ABRIL_VALENCIA_Dra.Iranzo.pdf/87a519b1-3dc2-4dc7-adae-a310f28a8215
Ellis M., Yu Tao Y., Luo J. et al. Outcome Prediction for Estrogen Receptor-Positive Breast Cancer Based on Postneoadyuvant Endrocrine Therapy Tumor Characteristics. JNCI. 2008; 100 (19): 1380-88.
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
